EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression

Christy Ilia, Ciara Walshe iD, Linh Nguyen, Chelsea Sammons, Maxwell Norris, Abigail Forte, Jennifer Trofe iD, Gregory Malat iD

Progress in Transplantation · 2026-06 · 36 (2) · 74-80

DOI: 10.1177/15269248261456512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Progress in Transplantation, online erschienen am 04.06.2026. Verfasst von Christy Ilia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Antilymphocyte Serum, Immunosuppressive Agents, Cost Savings. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Rabbit anti-thymocyte globulin (rATG) induction ideal dosing strategies in kidney transplant recipients have not been fully elucidated. Project Aims This study compares the impact of ideal body weight-based versus actual body weight-based rATG dosing on drug purchasing costs and kidney transplant outcomes.

Design

Retrospective, single-center chart review of kidney transplant recipients receiving rATG induction using (1) actual body weight-based dosing between May 17, 2019, and Mar 13, 2020, versus (2) ideal body weight-based dosing between May 17, 2022, and Mar 13, 2023. The primary endpoint is the rATG drug cost/kidney transplant recipient [measured by average wholesale price] compared between cohorts. Secondary endpoints are rates of biopsy-proven acute rejection, readmissions secondary to infection, myelosuppression (leukopenia or neutropenia), and viremia (Epstein-Barr virus, cytomegalovirus, and BK virus) measured for 6 months. Study design adhered to EQUATOR STROBE guidelines for reporting cohort studies.

Results

Overall, rATG ideal body weight-based dosing resulted in a median $3838 saved per kidney transplant recipients, based on average wholesale price, and a statistically significant reduction in cost versus actual body weight-based dosing ( P = .02). Secondary outcomes were generally similar between groups, with a difference in Epstein-Barr viremia ( P = .017) not translating to a significant difference in readmissions for infection ( P = .226).

Conclusion

Our institution conducts around 250 kidney transplants annually, and considering the majority will receive rATG induction, this dosing protocol estimates average wholesale price drug purchasing cost-savings of about $900 000/year without compromising early clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationAntilymphocyte SerumImmunosuppressive AgentsCost SavingsGraft RejectionImmunosuppression TherapyHumansFemaleRetrospective StudiesMaleAnimalsMiddle AgedBody WeightRabbitsAdult

Stichwörter der Autor:innen

immunosuppression therapykidney transplantationthymoglobulin

Substanzen

Antilymphocyte SerumImmunosuppressive Agents

Autor:innen und Institutionen

  • Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Penn Transplant Institute, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Renal and Hypertension, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Transplant Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

ORCID-Profile: Ciara Walshe, Jennifer Trofe, Gregory Malat

Zitieren

APA

Ilia, C., Walshe, C., Nguyen, L., Sammons, C., Norris, M., Forte, A., Trofe, J., & Malat, G. (2026). Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression. Progress in Transplantation, 36(2), 74-80. https://doi.org/10.1177/15269248261456512

Vancouver

Ilia C, Walshe C, Nguyen L, Sammons C, Norris M, Forte A, et al. Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression. Progress in Transplantation. 2026;36(2):74-80. doi:10.1177/15269248261456512

BibTeX
@article{Ilia2026,
  author = {Ilia, Christy and Walshe, Ciara and Nguyen, Linh and Sammons, Chelsea and Norris, Maxwell and Forte, Abigail and Trofe, Jennifer and Malat, Gregory},
  title = {Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression},
  journal = {Progress in Transplantation},
  year = {2026},
  volume = {36},
  number = {2},
  pages = {74--80},
  doi = {10.1177/15269248261456512}
}
Kostenlos starten →